1.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 1 to 30 Sponsor: NCI Protocol IDs: COG-AAML06P1, AAML06P1, NCT00469859
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: C701a/204/ON/US, NCT00079482
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: C0701a/203/ON/US, NCT00081601
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 2007-0070, CS-2007-20040, NCT00494585
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 30 and under at diagnosis Sponsor: NCI, Other Protocol IDs: CDR0000363630, P01CA081403, NANT-2001-03, NCT00084422
|